Skip to content
Home/Companies/Biotech/Abbisko Healthcare

Abbisko Healthcare

Biotech·China·Active
Entry
–
Hold
–
Status
Active

Who owns Abbisko Healthcare?

Abbisko Healthcare is a Chinese Biotech company, currently owned by The Carlyle Group.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
The Carlyle Group
Investor
The Carlyle Group
Carlyle Asia fund · 2021 · Growth

Key facts

HQChina
SectorBiotech

More from Carlyle Asia fund

Other portfolio companies in the same fund.

Abrigo
Abrigo
Active
SaaSUS
Acentra Health
Acentra Health
Active
HealthcareUS
Beautycounter
Exited 2024
ConsumerUS
Duravant
Duravant
Active
IndustrialsUS
Kokusai Kogyo Co., Ltd.
Exited 2023
ConstructionJapan
to MIRAIT ONE Corporation
neogov
neogov
Exited 2025
SaaSUS
to EQT and CPP Investments

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK

Questions

Who owns Abbisko Healthcare?

Abbisko Healthcare is currently owned by The Carlyle Group, through Carlyle Asia fund.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue